Recombinant Zoster Vaccine Works Well in Older Patients (FREE)

By Abigail Zuger, MD Dr. Zuger is an associate editor with NEJM Journal Watch General Medicine, from which this story was adapted. Full coverage is available to subscribers at the link below.A new two-dose recombinant zoster vaccine was 90% efficacious among adults older than 70 in an industry-supported, randomized trial published in the New …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news